Virtual Mentorship Session with SVP, R​&D, and Chief Scientific Officer, AbbVie




Virtual event on Zoom


Please join Dr. Thomas Hudson, Senior Vice Pre​sident, R​&D, and Chief Scientific Officer for AbbVie, for an intimate virtual roundtable discussion.

Our digital community will have the opportunity to partake in an intimate and candid discussion with a Q&A session.

For questions about the event: please email:

*YJP has a non-solicitation policy covering all of our conferences and events. In order to provide a distraction-free environment for our mentors, sponsors, attendees, and employees, we do not allow solicitation at our events by attendees or unauthorized parties without the express written permission or consent from YJP. The Corporation As A Citizen.” We will discuss the intersections of business, policy, public affairs and law that confront multinational public corporations and, in particular, focus on the obligations corporations owe to a broad array of stakeholders (e.g., investors, employees,, public and private sector creditors, communities, governments, activists and suppliers). 

7403f06f541b27989196de6a062b9c59f68eb9ed large
Dr. Thomas Hudson
Senior Vice Pre​sident, R​&D, and Chief Scientific Officer at AbbVie

Dr. Thomas Hudson serves as AbbVie’s Senior Vice President, R&D, and Chief Scientific Officer. In this role, he leads the company’s R&D organization and a global team of scientists who work across therapeutic areas to identify potential new treatments for a variety of diseases. Dr. Hudson leads R&D strategy for the company as well as for the many scientific partnerships AbbVie pursues.

Dr. Hudson joined AbbVie in 2016, overseeing oncology discovery and early development before assuming responsibilities for the entire discovery organization as Vice President, Discovery Research. ​

Prior to joining AbbVie, Dr. Hudson was the President and Scientific Director of the Ontario Institute for Cancer Research where he led the institute’s work in translational research for the prevention, detection, diagnosis and treatment of cancer. A Canadian genome scientist, Dr. Hudson wa​s a pioneer in mapping the human genome and is internationally renowned for his work in genomics, human genome variation and genetic diseases. Dr. Hudson has co-authored more than 300 peer-reviewed scientific publications. He received his M.D. from the University of Montreal.​

3a17bec8cd2441b146de3d2a7d7662b92eac261f large
Craig Stratsnick
President and CEO at Commonwealth Diagnostics International, Inc.

Craig S. Strasnick is a seasoned executive, experienced entrepreneur, and dynamic commercial leader. In his current
role as President and CEO of CDI, he partners with respected academics and industry leaders across the world to improve current gastroenterological practices. Craig drives the company’s mission by developing and introducing new patient friendly preventative health and monitoring technologies, as well as ensuring their clinical and commercial execution. Craig graduated from Northeastern University with a degree in Business Administration. In 2021, Forbes named Craig Strasnick and Commonwealth Diagnostics International to the Forbes Next 1000.
Craig founded CDI in 2015 after securing the acquisition of Commonwealth Laboratories Inc., a company at which he previously founded and served as COO from 2011-2016. Serving as COO, he built the company over a six-year period from a two-employee firm to a thriving business with over 100 employees across all 50 states, and in Canada.
Craig continues to drive the company forward by working hard to bring new, innovative and patient-centric preventative health and monitoring technologies to market that not only assist in enhancing the quality of life for the patients who use them, but also create cost- effective solutions for the healthcare system overall and provide value-added services for the many healthcare providers who could benefit from their use.
Craig currently serves as a member of the Board of Directors of AlphaLogic, Inc., a company specializing in the development and commercialization of convenient, low cost wearable sensory systems that can be deployed rapidly in the hospital, clinic, or at home for
the diagnosis and ongoing monitoring of digestive wellness; as well as MyTotalHealth, Inc., a company that was founded to empower patients to monitor, manage, and understand their symptoms for
Page 1 of 4
a range of conditions both within GI as well as in other areas of medicine.
Additionally, he is a member of the Board of Directors of Functional Gut Diagnostics Ltd, CDI’s joint venture partner and sister company in the United Kingdom providing CDI’s entire portfolio of technologies to the UK market.

Partial Guest List

Fbc59c3368865ea3ef84d537fbbd5d8e66a2974f thumb
D4c63d494615f33d0886ebd49a03122b4227d1e2 thumb
Cbc1340376ce08f95a6da80c588c057b2d54ebad thumb
E9a6069206fa77f502174a861d6c21618a5b8c2e thumb
Ff448fe9bd6a0423deef7a97caa885d6840e0a15 thumb
Users photos missing
A4f74454e1c7b902bcd815f5cd75530cd2ff52f1 thumb
Users photos missing
F6284e1428ca2616bc8271466c5dff1cf128fc80 thumb
D67fe04008d7ce54601c301710bd9f2134583b03 thumb
Users photos missing
C84991bab6bef4e68949aad3a3e1736948964845 thumb
Users photos missing
E291fe21950c6adb797413dba7af5ff91a0e4dfb thumb
4450a0c9c1ff699eb863205b5ff49556aee496a6 thumb
F5dafe03e65a6f185af3a8433366868c3d9b7254 thumb
Users photos missing
Register for this event